CRL vs GTBP · rev $2.00B vs $17.4M cap
Charles River Laboratories (CRL) versus GT Biopharma Inc (GTBP) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
GT Biopharma Inc (GTBP) is a biotechnology company listed on NASDAQ.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
GTBP does not have a complete income-statement cache yet.
CRL currently screens at market cap $7.78B. GTBP currently screens at market cap $17.4M.
Not investment advice. Open the CRL and GTBP stock pages for the full models.
Not investment advice.